Population dynamics of islet-infiltrating cells in autoimmune diabetes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 5, 2015, Pages 1511-1516

  Magnuson, Angela M ^a   Thurber, Greg M ^b,d   Kohler, Rainer H ^b   Weissleder, Ralph ^b   Mathis, Diane ^a,c   Benoist, Christophe ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cell tracer; Reporter; Treg

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; INSULITIS; LEUKOCYTE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PHENOTYPE; POPULATION DYNAMICS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY; T LYMPHOCYTE;

MUS MUSCULUS;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; IMMUNOLOGIC MEMORY; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 84922384689     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1423769112     Document Type: Article

References (49)

1. Wa˚llberg M, Cooke A (2013) Immune mechanisms in type 1 diabetes. Trends Immunol 34(12):583-591.
2. Jörns A, et al. (2014) Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia 57(3):512-521.
3. Anderson MS, Bluestone JA (2005) The NOD mouse: A model of immune dysregulation. Annu Rev Immunol 23:447-485.
4. Lee Y, et al. (2006) Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity 25(3):499-509.
5. In't Veld P (2011) Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 3(4):131-138.
6. Imagawa A, et al. (2001) Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: Close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50(6):1269-1273.
7. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155(2):173-181.
8. In't Veld P, et al. (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56(9):2400-2404.
9. Coppieters KT, et al. (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J ExpMed 209(1):51-60.
10. Arif S, et al. (2014) Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 63(11):3835-3845.
11. Lennon GP, et al. (2009) T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31(4):643-653.
12. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV (2003) Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 197(5):643-656.
13. Calderon B, Carrero JA, Miller MJ, Unanue ER (2011) Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci USA 108(4):1561-1566.
14. Stratmann T, et al. (2003) Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J Clin Invest 112(6):902-914.
15. Chee J, et al. (2014) Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes. J Immunol 192(2):572-580.
16. Peterson JD, Berg R, Piganelli JD, Poulin M, Haskins K (1998) Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones. Cell Immunol 189(2):92-98.
17. Calderon B, Carrero JA, Miller MJ, Unanue ER (2011) Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci USA 108(4):1567-1572.
18. Christen U, et al. (2004) Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 113(1):74-84.
19. Tomura M, et al. (2008) Monitoring cellular movement in vivo with photoconvertible fluorescence protein "Kaede" transgenic mice. Proc Natl Acad Sci USA 105(31):10871-10876.
20. Tomura M, et al. (2010) Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 120(3):883-893.
21. + T cells with a distinct phenotype and migratory pattern. J Immunol 190(3):970-976.
22. Morton AM, et al. (2014) Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc Natl Acad Sci USA 111(18):6696-6701.
23. Jansen A, et al. (1994) Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43(5):667-675.
24. Miyazaki A, et al. (1985) Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study. Clin Exp Immunol 60(3):622-630.
25. Carrero JA, Calderon B, Towfic F, Artyomov MN, Unanue ER (2013) Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS ONE 8(3):e59701.
26. Böhme J, Schuhbaur B, Kanagawa O, Benoist C, Mathis D (1990) MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249(4966):293-295.
27. Lee KU, Amano K, Yoon JW (1988) Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37(7):989-991.
28. Calderon B, Unanue ER (2012) Antigen presentation events in autoimmune diabetes. Curr Opin Immunol 24(1):119-128.
29. Ando R, Hama H, Yamamoto-Hino M, Mizuno H, Miyawaki A (2002) An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein. Proc Natl Acad Sci USA 99(20):12651-12656.
30. Hara M, et al. (2004) A mouse model for studying intrahepatic islet transplantation. Transplantation 78(4):615-618.
31. von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343(14):1020-1034.
32. Mellanby RJ, Thomas D, Phillips JM, Cooke A (2007) Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 121(1):15-28.
33. Wang J, et al. (2010) In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation. Proc Natl Acad Sci USA 107(20):9317-9322.
34. André I, et al. (1996) Checkpoints in the progression of autoimmune disease: Lessons from diabetes models. Proc Natl Acad Sci USA 93(6):2260-2263.
35. Chatenoud L, Bluestone JA (2007) CD3-specific antibodies: A portal to the treatment of autoimmunity. Nat Rev Immunol 7(8):622-632.
36. Keymeulen B, et al. (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352(25):2598-2608.
37. Herold KC, et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346(22):1692-1698.
38. Keymeulen B, et al. (2010) Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 53(4):614-623.
39. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91(1):123-127.
40. Nishio J, Feuerer M, Wong J, Mathis D, Benoist C (2010) Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints. J Exp Med 207(9):1879-1889.
41. + lymphocytes to CD3 engagement: Clues to a possible mechanism of anti-CD3 action? J Immunol 191(7):3694-3704.
42. Herold KC, et al. (2005) A single course of anti-CD3 monoclonal antibody hOKT3-gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54(6):1763-1769.
43. Höglund P, et al. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189(2):331-339.
44. Gagnerault MC, Luan JJ, Lotton C, Lepault F (2002) Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med 196(3):369-377.
45. Friedman RS, et al. (2014) An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function. Proc Natl Acad Sci USA 111(25):9223-9228.
46. Fan Z, et al. (2010) In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. Nat Med 16(6):718-722.
47. +cells in progressive autoimmune insulitis in the NOD mouse model of type 1 diabetes. Diabetologia 56(12):2669-2678.
48. Tang Q, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28(5):687-697.
49. Hönninen A, et al. (1993) Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 92(5):2509-2515.